← Leaderboards
Cheemeng Tan
University Of California At Davis
$3,731,822
Attributed
$5,148,589
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,148,589 · 4
By mechanism
R35$2,326,864 · 1
R01$1,844,687 · 1
R21$977,038 · 2
Top collaborators
- Randy Carney5 shared
- Aijun Wang5 shared
- Russell C Hovey2 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Thomas Michael Young$1,167,632
- Anthony G. Passerini$1,591,329
- Jun Yang$1,729,357
- Candace Bever$773,586
- Gerardo Guillermo Mackenzie$2,170,462
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsCellsEngineeringInterestDrug Delivery SystemsDoseMolecularFutureGenesPreventMutationGrowthMetabolismSiteClustered Regularly Interspaced Short Palindromic RepeatsGene ExpressionProtein BiosynthesisInformation ProcessingBacteriaPublic Health RelevanceDrug SynthesisHuman BodyEcosystemHybrids
Grant awards (19)
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$574,350
R01 · FY2025 · EB · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$381,008
R35 · FY2025 · GM · contact PI
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$91,988
R01 · FY2025 · EB · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$68,839
R35 · FY2025 · GM · contact PI
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$561,799
R01 · FY2024 · EB · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$381,008
R35 · FY2024 · GM · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$86,051
R35 · FY2024 · GM · contact PI
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$45,994
R01 · FY2024 · EB · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$17,125
R35 · FY2024 · GM · contact PI
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$570,556
R01 · FY2023 · EB · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$381,008
R35 · FY2023 · GM · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$249,809
R35 · FY2023 · GM · contact PI
Engineering non-proliferating-but-active (NPBA) probiotic for breast-cancer gene therapy$167,325
R21 · FY2023 · CA · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$381,008
R35 · FY2022 · GM · contact PI
Engineering non-proliferating-but-active (NPBA) probiotic for breast-cancer gene therapy$206,627
R21 · FY2022 · CA · contact PI
Dissecting the non-growing-but-active state of a hybrid bacteria-material microdevice$381,008
R35 · FY2021 · GM · contact PI
Modeling heterogeneity of a cancer-signaling cascade using biomimetic cells$226,787
R21 · FY2021 · EB · contact PI
Modeling heterogeneity of a cancer-signaling cascade using biomimetic cells$187,952
R21 · FY2020 · EB · contact PI
Modeling heterogeneity of a cancer-signaling cascade using biomimetic cells$188,347
R21 · FY2019 · EB · contact PI